Zei Uwadia made national headlines in 2018 when she walked the halls of Children's Mercy Kansas City while on life support. All told, she spent more than six months connected to an extracorporeal membrane oxygenation (ECMO) machine while battling a mysterious lung ailment. That work focuses on trimethoprim-sulfamethoxazole, more commonly known as Bactrim

Carson Dodd is still hooping while receiving the highest form of life support after his lungs failed.

A young girl from Springfield had lung failure shortly after taking a very common antibiotic, Bactrim. Since then, the FDA is issuing a new warning of acute respiratory failure associated with that drug, which some patients believe caused death.

Doctors from Children's Mercy in Kansas City published a medical study in the Pediatrics journal. They studied five previously healthy young patients. Of the five patients in the study, two died, four were considered for organ transplants and all experienced lung failure.

Trimethoprim-sulfamethoxazole (TMP-SMX) treatment may be linked to the onset of severe acute respiratory distress syndrome (ARDS) in adolescents, according to a recent case series published online May 31 in Pediatrics.

Trimethoprim-sulfamethoxazole was linked to severe respiratory distress syndrome in five previously healthy teens, two of whom died.

A documentary from Children’s Mercy Kansas City about the story of Zei Uwadia and her long battle with ECMO.

For the past 467 days, Zei Uwadia has been hospitalized on life support – but that hasn’t kept the quiet-natured teenager from walking.